Effects of topical flutamid on melasma lesions
Phase 3
- Conditions
- Melasma.
- Registration Number
- IRCT138905114310N4
- Lead Sponsor
- Ardebil medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
1- Females with melasma
2- Consent to participate
Exclusion criteria:
1- Pregnancy
2- Breastfeeding
3- Taking OCP, spironolactone or phenytoein
4- Receiving antipigmentation therapy during the last four months
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction of pigmentation. Timepoint: 30 day. Method of measurement: Photography-Mexameter-Clinical examination-Patient satisfaction.
- Secondary Outcome Measures
Name Time Method Side effects of drugs. Timepoint: One months. Method of measurement: Clinical examination.;Patient satisfaction. Timepoint: 3 months. Method of measurement: Check list.